← Open Payments lookup

ABIGAIL SCHELLHAMMER: Open Payments

NPI 1508239534 · LANSING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,595 in 201 payments from 18 companies in 2025. Trend: 2023 $554 · 2024 $1,555 · 2025 $2,595

Food & beverage: $2,595
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)28$352
Vanda Pharmaceuticals Inc.18$267
Teva Pharmaceuticals USA, Inc.18$266
ABBVIE INC.23$259
Supernus Pharmaceuticals, Inc.35$254
Otsuka America Pharmaceutical, Inc.18$232
E.R. Squibb & Sons, L.L.C.18$226
Corium, LLC11$155
Neurocrine BioSciences, Inc.9$139
Janssen Pharmaceuticals, Inc5$106

Products named: CAPLYTA, FANAPT, VRAYLAR, Qelbree, COBENFY, Azstarys, AUSTEDO XR, INGREZZA.

Industry payments across MI — which companies pay providers there.